DEC 16, 2016 12:33 PM PST

Potential New Drug Target For Epilepsy

WRITTEN BY: Jennifer Ellis

Epilepsy is one of the most common neurological diseases worldwide, affecting more than 50 million people. Epilepsy is characterized by seizures ranging from brief and barely detectable to severe episodes of shaking and convulsions. The neurological disease doesn’t seem to have a direct cause but is known to be due to incorrect or excessive firing of neurons.  

Research has shown that there is a genetic component to epilepsy, however, many cases are caused by trauma or stroke. And despite the more than 30 types of medications available to help treat epileptic seizures, there are still an estimated one third of patients who have uncontrollable symptoms.

Scientists at the Imperial College London recently discovered an ‘epileptic network’ of genes that are associated with epilepsy and might lead to a new approach to treatment. The group of 320 genes, called M30, is thought to be involved in cell to cell communication in the brain. The study is published in Genome Biology.

VPA, a commonly used AED with a wide range of clinical efficacy, is the one that is most significantly predicted to restore the expression of M30 in epilepsy toward health. (MR Johnson et al, 2016)

Dr. Michael Johnson, senior author of the study, explains that any malfunction in this network can trigger epilepsy. By developing new therapies to repair the network, clinicians could treat epilepsy at its initial source and possibly halt seizures. Potential treatments are not limited to genetic causes either. The network seems to be broken in both epileptic cases caused by genetic mutations and in those caused by injury such as stroke or infection.

The team used systems biology and expression network analysis to examine thousands of genes and mutations associated with epilepsy. They also looked at expression data from healthy human brains to find networks of these genes that work together and from mice to confirm that when these networks malfunction they cause epileptic seizures. They observed that M30 contains several genes that are downregulated in many different types of epilepsy.

“Until recently we have been looking for individual genes associated with diseases, which drug companies then target with treatments. However, we are increasingly aware that genes don’t work in isolation. Identifying groups of genes that work together, and then targeting these networks of genes, may lead to more effective treatments. Our proof of concept study suggests this network biology approach could help us identify new medications for epilepsy, and the methods can also be applied to other diseases.”

After zeroing in on the M30 network, researchers virtually tested 1,300 known seizure associated treatments to see which ones affected the functioning of the network and which ones could restore any issues. They found two drugs that seemed to have substantial effects on seizure intensity and frequency; one is a known epileptic treatment and the other had not previously been used in standard therapy.

Using differential expression analysis of the genes based on drug exposure, the scientists saw a dose-dependent effect on M30 with Valproic Acid, a known epileptic medication, and suggested that higher doses of the medication would produce a greater therapeutic effect.

The screen also highlighted a new network-drug interaction with whitaferin A, a steroidal lactone contained in the Indian ginseng plant that has been used in Ayurvedic medicine for treatment of a wide range of diseases including epilepsy. Additional studies of whitaferin A in animal models have reported the anticonvulsive effect of this drug.

Johnson suggested that network biology, the computational analysis method used in the study, could be used to identify gene networks associated with other diseases, resulting in new approaches to finding treatments and novel therapies.

Sources: Genome Biology, Science and Technology Research

About the Author
  • I love all things science and am passionate about bringing science to the public through writing. With an M.S. in Genetics and experience in cancer research, marketing and technical writing, it is a pleasure to share the latest trends and findings in science on LabRoots.
You May Also Like
DEC 06, 2019
Cell & Molecular Biology
DEC 06, 2019
A New Theory About the Structure of DNA
Scientists have new ideas about how the helixes of the DNA molecule are linked together....
DEC 06, 2019
Microbiology
DEC 06, 2019
A Bacterial Pathogen Can Steal Huge Chunks of DNA From Other Microbes
Microorganisms are everywhere, and they are often engaged in a fight for resources with other microbes....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Super-Resolution Microscopy Reveals How DNA Damage is Repaired
People that don't carry functional copies of these proteins are more likely to get diseases that arise from unstable DNA....
DEC 06, 2019
Microbiology
DEC 06, 2019
Pathogenic E. coli Tends to Come From Poor Hygiene, Not Contaminated Food
A new study has shown that antibiotic-resistant E. coli spreads primarily because of poor hygiene....
DEC 06, 2019
Neuroscience
DEC 06, 2019
ADHD and Autism Share the Same Genes
In the US, 1 in every 59 children has autism, with 1 in every 20 having ADHD. Now, researchers from Denmark’s national psychiatric project, iPSYCH, h...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Depression is Not Caused By Genetics
Since the discovery of DNA, attributing the cause of illnesses to genetic reasons became trendy. Depression was no exception- with hundreds of studies havi...
Loading Comments...